Parkinson's Disease


Up to $1600


12 weeks

Parkinson’s Disease

Official Title

Parkinson's Disease

Study Summary

Subjects stable on L-Dopa and oral ropinirole will have their ropinirole replaced with the Ropinirole Implant(s). The Ropinirole Implant was designed using the ProNeura™ implant technology where the implant is inserted under the skin. This study will measure how much ropinirole is released in the blood during 3 months of treatment, and evaluate the side effects of this new formulation

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 30+
Inclusion Stable dose of Carbidopa/Levodopa and Ropinirole for at least 30 days
Exclusion Severe dementia or cognitive impairment
Start Date
Compensation Up to $1600
Location Orlando, FL

Study Information

Condition Parkinson's Disease
Study Phase Phase 2

Administrative Information

Investigators Ira J Goodman, MD

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.

At Synexus we take your privacy seriously. By clicking apply, you agree to our privacy policy, and agree that we may share your information with our affiliates or otherwise as described in our privacy policy, and we or our affiliates may contact you by email, phone, including using automated technology or pre-recorded voicemail or other means regarding research studies.

Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.